A detailed history of Prosperity Consulting Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Prosperity Consulting Group, LLC holds 26,427 shares of ABBV stock, worth $4.7 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
26,427
Previous 23,776 11.15%
Holding current value
$4.7 Million
Previous $4.08 Million 27.95%
% of portfolio
0.41%
Previous 0.57%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $434,339 - $528,423
2,651 Added 11.15%
26,427 $5.22 Million
Q2 2024

Aug 08, 2024

SELL
$154.79 - $180.76 $1.01 Million - $1.17 Million
-6,498 Reduced 21.46%
23,776 $4.08 Million
Q1 2024

May 01, 2024

BUY
$159.82 - $182.1 $3.4 Million - $3.88 Million
21,304 Added 237.5%
30,274 $5.51 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $134,985 - $152,025
981 Added 12.28%
8,970 $1.39 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $798,601 - $924,497
5,978 Added 297.27%
7,989 $1.19 Million
Q2 2023

Jul 25, 2023

BUY
$132.51 - $164.9 $1,457 - $1,813
11 Added 0.55%
2,011 $270,000
Q1 2023

Apr 24, 2023

SELL
$144.61 - $166.54 $8,531 - $9,825
-59 Reduced 2.87%
2,000 $318,000
Q4 2022

Feb 08, 2023

BUY
$138.31 - $165.87 $284,780 - $341,526
2,059 New
2,059 $332,000
Q2 2022

Jul 25, 2022

SELL
$137.62 - $174.96 $2,477 - $3,149
-18 Reduced 0.96%
1,862 $285,000
Q1 2022

Apr 19, 2022

SELL
$131.98 - $163.75 $131 - $163
-1 Reduced 0.05%
1,880 $305,000
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $202,075 - $255,684
1,881 New
1,881 $261,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Prosperity Consulting Group, LLC Portfolio

Follow Prosperity Consulting Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosperity Consulting Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prosperity Consulting Group, LLC with notifications on news.